
    
      1. Study subjects : Parkinson disease who are on Requip or Mirapex and are considering to
           change into Mirapex ER

        2. Cross over study design:

             -  Group 1: Once daily dose for 2 month then into BID in divided dose for 2 months

             -  Group 2: BID in divided dose for 2 months then into QD dose for 2 months

        3. Dose adjustment may be done in the first 4 weeks.

        4. Compare the benefit, side effects, and patient preference between the QD vs BID dosing
    
  